Targeted-Capture Sequencing Approach to V(D)J Rearrangement, Immunoglobulin (Ig) Translocation and Mutation Detection in Multiple Myeloma (MM): Potential Applications in Minimal Residual Disease (MRD) Analysis and Comparison to Multiparameter Flow Cytometry (MFC) in the Myeloma Canada Research Network (MCRN) 001 Study with Intravenous Busulfan and Melphalan (BuMel) Conditioning Followed By Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM)

Signy Chow,Donna Reece,Jonathan J Keats,P Leif Bergsagel,Nizar J Bahlis,Paola Neri,Giovanni Piza Rodriguez,Michael Sebag,Darrell J White,Kevin Song,Terrance Comeau,Christopher P Venner,Christine I Chen,Jean Roy,Martha L Louzada,Julie Stakiw,Andrea Kew,Vishal Kukreti,Anca Prica,Rodger Tiedemann,Mariela Aura Pantoja,Harminder Kaur Paul,Trevor J Pugh,Suzanne Trudel

doi:10.1182/blood.v130.suppl_1.3057.3057

Targeted-Capture Sequencing Approach to V(D)J Rearrangement, Immunoglobulin (Ig) Translocation and Mutation Detection in Multiple Myeloma (MM): Potential Applications in Minimal Residual Disease (MRD) Analysis and Comparison to Multiparameter Flow Cytometry (MFC) in the Myeloma Canada Research Network (MCRN) 001 Study with Intravenous Busulfan and Melphalan (BuMel) Conditioning Followed By Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM)

Signy Chow, Donna Reece + Show 22 more

https://doi.org/10.1182/blood.v130.suppl_1.3057.3057

Copy DOI

Journal: Blood

Publication Date: Jun 25, 2021

Affiliation: University of Toronto, Ottawa Hospital, Université de Montréal, University of Calgary, Dalhousie University

#Research Funding #Bone Marrow Samples + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Targeted-Capture Sequencing Approach to V(D)J Rearrangement, Immunoglobulin (Ig) Translocation and Mutation Detection in Multiple Myeloma (MM): Potential Applications in Minimal Residual Disease (MRD) Analysis and Comparison to Multiparameter Flow Cytometry (MFC) in the Myeloma Canada Research Network (MCRN) 001 Study with Intravenous Busulfan and Melphalan (BuMel) Conditioning Followed By Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM)

Full Text